Pluronic P85 Enhances the Delivery of Phenytoin to the Brain Versus Verapamil In Vivo

Ziyan Fang,Shuda Chen,Yishu Chen,Guanzhong Ni,Jiaming Qin,Libai Yang,Ziyi Chen,Jueqian Zhou,Min Huang,Chuanbin Wu,Ze Li,Liemin Zhou
IF: 6.74
2014-01-01
Epilepsia
Abstract:In order to find out that whether Pluronic P85 could deliver phenytoin (PHT) to brain targeted or not, a bolus dose of PHT (35 mg/kg, i.v.) in PBS as blank control or in different concentrations of Pluronic P85 solution (0.1, 1, and 10%, m/v) was administered intravenously in rats. And another group of rats as positive control was administered of verapamil (VPM, 10 mg/kg, i.p.) 30 min prior to PHT injection. Samples of plasma and dialysate in brain were collected at 30, 60, 120, 180, 240 and 300 min after PHT administration in each rat. After termination of the experiment, liver and kidney were removed for study on drug distribution in tissues. Compared with VPM, Pluronic P85 produced a dose-dependent effect on PHT distribution in hippocampus, and it significantly increased PHT concentration in ECF of hippocampus after systemic administration. And there were no increase of PHT distribution in liver and kidney in Pluronic P85 groups, while the accumulation of PHT in liver had a significantly increase in VPM group, compared with PHT blank control group. These data indicated that Pluronic P85 could enhance the distribution of PHT in brain, and the usage of Pluronic P85 as an antiepileptic drugs delivery system to brain targeted might constitute an interesting novel approach for treatment of pharmacoresistant epilepsy.
What problem does this paper attempt to address?